Complications of sclerotherapy: An update

Dermatologic Surgery

Volumn 36, Issue SUPPL. 2, 2010, Pages 1056-1063

  Guex, Jean Jérôme ^a  

^a Cabinet de Phleblogie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCEROL; IODINE; MORRHUATE SODIUM; POLIDOCANOL; SCLEROSING AGENT; TETRADECYL SULFATE SODIUM;

ANAPHYLACTIC SHOCK; ANAPHYLAXIS; CHEST TIGHTNESS; COUGHING; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DIZZINESS; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; DRUG SAFETY; FOAM SCLEROTHERAPY; FRANCE; HUMAN; INCIDENCE; INFORMED CONSENT; LIQUID SCLEROTHERAPY; LUNG EMBOLISM; MIGRAINE; MYOCARDIAL DISEASE; NEOVASCULARIZATION (PATHOLOGY); PAIN; PIGMENT DISORDER; PRIORITY JOURNAL; REGISTER; REVIEW; SCLEROTHERAPY; SCOTOMA; SKIN BRUISING; SKIN NECROSIS; STROKE; SYNCOPE; THROMBOPHLEBITIS; TISSUE NECROSIS; TRANSIENT ISCHEMIC ATTACK; VARICOSIS; VISUAL DISORDER;

FRANCE; HUMANS; SCLEROSING SOLUTIONS; SCLEROTHERAPY;

EID: 77952916751     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2009.01409.x     Document Type: Review

References (53)

1. Guex J-J, Allaert F-A, Gillet J-L, Chleir F. Immediate and midterm complications of sclerotherapy. Report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg 2005 31 : 123 128.
2. The American Heritage Dictionary of the English Language. 4th ed.
3. The American Heritage Medical Dictionary. New updated ed.
4. Babbush CA, editor. Mosby's Dental Dictionary. 2nd ed.
5. Blood DC, Studdert VP, Gay CC, editors. Saunders Comprehensive Veterinary Dictionary. 3rd ed.
6. ENTR/CT 3 Rev 2 Detailed guidance on the collection, verification and presentation of adverse reaction reports arising from clinical trials on medicinal products for human use. Annex 1: Comments on definitions and abbreviations. Brussels; 2006, p 15. Available at : (accessed Oct 24, 2008).
7. Varcoe PF. Ultrasound guided sclerotherapy: efficacy, adverse effects and dosing. An international survey. Aust N Z J Phlebol 2003 7 : 17 24.
8. Goldman MP, Bergan JJ, Guex JJ. Complications and adverse sequelae of sclerotherapy. In : Goldman MP, Bergan JJ, Guex J-J, editors. Sclerotherapy. Treatment of varicose and telangiectatic leg veins. 4th ed.
9. Conrad P, Malouf GM, Stacey MC. The Australian polidocanol study. Dermatol Surg 1995 21 : 334 336.
10. Alos P, Carrreno P, Lopez JA, et al. Efficacy and safety of sclerotherapy using Polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg 2006 31 : 101 107.
11. Geukens J, Rabe E, Bieber T. Embolia cutis medicamentosa of the foot after sclerotherapy. Eur J Dermatol 1999 9 : 132 133.
12. Kersting E, Hornschuh, Bröcker EB. Embolia cutis medicamentosa nach Varizensklerosierung mit Polidocanol. Phlebologie 1998 27 : 55 7.
13. Gillet JL, Guedes JM, Guex JJ, et al. Side effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients (abstract). 9th Annual Meeting of the European Venous Forum; 2008 June 26-28; Barcelona.
14. Benigni JP, Ratinahirana H. Mousse de Polidocaol et migraine à aura. Phlébologie 2003 56 : 289 291.
15. Künzlberger B, Pieck C, Altmeyer P, Stücker M. Migraine ophtalmique with reversible scotomas after sclerotherapy with liquid 1% Polidocanol. Dermatol Surg 2006 32 : 1410 1413.
16. Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 2003 107 : 5 9. (Pubitemid 36070923)
17. Dowson A, Mullen MJ, Peatfield R, et al. Migraine intervention with STARFlex technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008 117 : 1397 1404.
18. Breu FX, Guggenbichler S, Wollmann J-C. 2nd European Consensus Meeting on foam sclerotherapy 2006, Tegernsee, Germany. VASA 2008 37 (Suppl 71) : 1 30.
19. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 2006 43 : 162 164.
20. Hanisch F, Müller T, Krivocuca M, Winterholler M. Stroke following variceal sclerotherapy. Eur J Med Res 2004 9 : 282 284.
21. Busch RG, Derrick M, Manjoney D. Major neurological events following foam sclerotherapy. Phlebology 2008 23 : 189 192.
22. Kas A, Begue M, Nifle C, et al. Cerebellar infarction after sclerotherapy for leg varicosities. Presse Med 2000 29 : 1935.
23. Ceulen RPM, Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med 2008 358 : 1525 1526.
24. Morrison N, Neuhardt DL, Rogers CR, et al. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg 2008 47 : 830 836.
25. Bergan J, Pascarella L, Mekenas L. Venous disorders: treatment with sclerosant foam. J Cardiovasc Surg 2006 47 : 9 18.
26. Rabe E, Otto J, Schliephake D, Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardised Polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Eur J Vasc Endovasc Surg 2008 35 : 238 245.
27. Yamaki T, Nozaki M, Sasaki K. Acute massive pulmonary embolism following high ligation combined with compression sclerotherapy for varicose veins. Dermatol Surg 1999 25 : 321 325.
28. Deichmann B, Blüm G. Apoplektischer Insult nach Sklerotherapie. Phlebologie 1995 24 : 148 152.
29. Hamel-Desnos C, Guias B, Quehé P, et al. Onséquences biologiquessur le sang circulant de la sclérothérapie à la mousse. Essai contrôlé randomisé avec ou sans compression post-porocédure. Abstract 7° congrès de la Société Française de Médecine Vasculaire. J Mal Vasc 2008 33 : s74 8.
30. Hamel-Desnos C, Desnos P, Guias B. Sclérothérapie mousse et thrombophilie. Phlébologie 2005 4 : 327 337.
31. ® Sodium Tetradecyl Sulfate. Bioniche Pharma USA. rev.10/04. Available at : (accessed Oct 24, 2008).
32. Stricker BH, van Oijen JA, Kroon C, Ovink AH. Anafylaxie na gebruik van Polidocanol. Ned Tijdschr Geneeskd 1990 134 : 240 242.
33. ® accusé à tort d'entraîner une mort subite. Acta Clin Belg 2006 61 (Suppl 1) : 51 3.
34. Blaise S, Olive K, Seinturier C, et al. Toxicité myocardique de l'Aetoxiscléroel. Abstract 6° congrès de la société Française de médecine vasculaire. J Mal Vasc 2007 32 : s68.
35. Geslin J-M, Bénabés B, Rodor F, et al. Manifestations respiratoires allergiques lors de sclérose de varices par le Lauromacrogol 400. Thérapie 2004 59 : 651 653.
36. ®. J Dermatol Surg Oncol 1993 19 : 959 961.
37. Feied CF, Jackson JJ, Bren TS, et al. Allergic reactions to polidocanol for vein sclerosis. Two case reports. J Dermatol Surg Oncol 1994 20 : 466 468.
38. Pradalier A, Vincent D, Hentschel V, et al. Allergie aux sclérosants des varices. Rev Fr Allergol 1995 35 : 440 443.
39. Jenkins D. Severe idiosyncratic reaction to polidocanol. Aust N Z J Phlebol 2002 6 : 24 5.
40. Goldman MP, Sadick NS, Weiss RA. Cutaneous necrosis, telangiectatic matting, and hyperpigmentation following sclerotherapy. Etiology, prevention, and treatment. Dermatol Surg 1995 21 : 19 29.
41. Munavalli GS, Weiss RA. Complications of sclerotherapy. Semin Cutan Med Surg 2007 26 : 22 8.
42. Kern P, Ramelet AA, Wutschert R, et al. Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins. Dermatol Surg 2004 30 : 367 372.
43. Scultetus AH, Villavicencio JL, Kao T-C, et al. Microthrombectomy reduces postsclerotherapy pigmentation: multicenter randomized trial. J Vasc Surg 2003 38 : 896 903.
44. Guex J-J. Inutilité de la compression après sclérothérapie des micro-varices et télangiectasies. Phlébologie 1994 47 : 371 375.
45. Guex J-J. Microsclerotherapy. Semin Dermatol 1993 12 : 129 134.
46. Minimizing and treating complications. In : Weiss RA, Feied CF, Weiss MA, editors. Vein diagnosis and treatment: a comprehensive approach.
47. Masuda EM, Kessler DM, Lurie F, et al. The effect of ultrasound-guided sclerotherapy of incompetent perforator veins on venous clinical severity and disability scores. J Vasc Surg 2006 43 : 551 556.
48. Bergan JJ, Weiss RA, Goldman MP. Extensive tissue necrosis following high-concentration sclerotherapy for varicose veins. Dermatol Surg 2000 26 : 535 542.
49. Cho YP, Kim E, Choi S-J, et al. Compartment syndrome after compression sclerotherapy. Ann Vasc Surg 2005 19 : 428 430.
50. Zipper SG. Nervus peronäus-Schaden nach Varizensklerosierung mit Aethoxysklerol. Einzelfallbeschreibung unter Berücksichtigung haftungsrelevanter Fragen. Versicherungmedizin 2000 52 : 185 187.
51. Jia X, Mowatt G, Burr JM, et al. Systematic review of foam sclerotherapy for varicose veins. BJS 2007 94 : 925 936.
52. Guex J-J. Les Contre-indications de la sclérothérapie, mise à jour. J Mal Vasc 2005 30 : 144 149.
53. Morrison N. Foam sclerotherapy. How to improve results and reduce side effects? Phlebologie 2008 37 : 211 220.